LONE ASCHERL ANDERSEN
Pharmacy in Ann Arbor, MI
License number
Michigan 4301059457
Expiration Date
Jan 31, 2015
Category
Pharmacy
Type
CS - 3
Address
Address
Ann Arbor, MI 48103
Personal information
See more information about LONE ASCHERL ANDERSEN at radaris.comName
Address
Phone
2375 Newport Rd, Ann Arbor, MI 48103
208 Division St, Ann Arbor, MI 48104
604 Ames Ct, Bay City, MI 48708
700 Borton Ave, Essexville, MI 48732
Professional information
See more information about LONE ASCHERL ANDERSEN at trustoria.com
Dr. Lone A Andersen, Ann Arbor MI - MD (Doctor of Medicine)
Dr. Lone A Andersen, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
2375 Newport Rd, Ann Arbor 48103
Certifications:
Dermatology, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Aarhus University
Aarhus University
Neurofibromatosis Gene
Neurofibromatosis Gene
US Patent:
5859195, Jan 12, 1999
Filed:
May 25, 1995
Appl. No.:
8/449933
Inventors:
Francis S. Collins - Ann Arbor MI
Margaret R. Wallace - Ann Arbor MI
Douglas A. Marchuk - Ann Arbor MI
Lone B. Andersen - Ann Arbor MI
David H. Gutmann - Ann Arbor MI
Margaret R. Wallace - Ann Arbor MI
Douglas A. Marchuk - Ann Arbor MI
Lone B. Andersen - Ann Arbor MI
David H. Gutmann - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C07K 14435, C07H 2104
US Classification:
530350
Abstract:
The entire coding region of the gene involved in von Recklinghausen neurofibromatosis (NF1) and a ubiquitously expressed large transcript (NF1LT) of the gene have been identified, cloned and sequenced. With the identification of the NF1 gene and its gene product, nucleic acid probes and antibodies raised to the gene product can be used in a variety of hybridization and immunological assays to screen for NF1 and detect it in its early stages. Conventional and gene therapies can also be developed to treat those afflicted with the disease.
Neurofibromatosis Gene
Neurofibromatosis Gene
US Patent:
6238861, May 29, 2001
Filed:
Aug 2, 1993
Appl. No.:
7/966049
Inventors:
Francis S. Collins - Ann Arbor MI
Margaret R. Wallace - Ann Arbor MI
Douglas A. Marchuk - Ann Arbor MI
Lone B. Andersen - Ann Arbor MI
David H. Gutmann - Ann Arbor MI
Margaret R. Wallace - Ann Arbor MI
Douglas A. Marchuk - Ann Arbor MI
Lone B. Andersen - Ann Arbor MI
David H. Gutmann - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 168, C12P 1934, C07H 2104, C07K 14435
US Classification:
435 6
Abstract:
The invention relates to the gene involved in the von Recklinghausen neurofibromatosis (NF1) disease process and to the identification, isolation and cloning of a nucleic acid sequence corresponding to the gene. The invention further relates to the NF1 gene product and sequence and antibodies raised thereto. The invention also relates to methods of screening for NF1 and NF1 diagnosis, as well as conventional treatment and gene therapy utilizing recombinant technologies.